Aktiesnakken — April 2023
-
Asien: Hold i rentestigning styrker asiatiske aktier https://www.proinvestor.com/investornyt/967848/asien-hold-i-rentestigning-styrker-asiatiske-aktier
-
Fredagens danske avisuddrag med Novo, banker og Salling
Grouphttps://www.proinvestor.com/investornyt/967849/fredagens-danske-avisuddrag-med-novo-banker-og-salling-group -
Shortpositioner i danske aktier
https://www.proinvestor.com/boards/112019 -
Mornings og god dag
-
Nordea løfter DSV "We maintain our Buy recommendation and raise our target price to DKK 1,470 (1,420), based 60% on a DCF model and 40% on relative valuation. We leave our 2023 estimates largely unchanged but lower 2024E-25E very marginally. For 2023, we lower our volume growth estimates to -4% and -7% for sea and air freight, respectively, although this is offset by higher yield assumptions. We estimate 2023 EBIT of DKK 16.9bn, compared to guidance of DKK 16-18bn and Refinitiv consensus at DKK
-
Skulle der ikke være kommet nyt fra FDA om Lundbeck?
-
Det burde der komme VK.
-
Tak. Altid spændende med den slags. Bliver det til dyr rødvin eller en halvflad pilsner. God weekend.
-
Lundbeck afventer Rexulti-nyt fra eksperter – kommer senere fredag https://borsen.dk/nyheder/virksomheder/lundbeck-afventer-rexulti-nyt-fra-eksperter-kommer-senere-fredag?b_source=borsen&b_medium=row_2&b_campaign=list_3
-
Lundbeck: FDA-eksperter stemmer for godkendelse af stort medicinhåb
Eksperter under de amerikanske sundhedsmyndigheder, Food and Drug Administration (FDA), har fredag aften stemt for en godkendelse af Lundbeck og partneren Otsuka Pharmaceuticals' Brexpiprazol til beha
borsen.dk (borsen.dk)
-
Gode og velfunderede betragtninger som altid, Mr. Eliot, så også tusinde tak herfra
-
God morgen og weekend
-
God morgen og godt med FDA og
Lundbeck -
This Stock Market Indicator Has Been 100% Accurate Since 1950: Here's What It's Saying Now https://www.proinvestor.com/investornyt/968375/this-stock-market-indicator-has-been-100-accurate-since-1950-heres-what-its-saying-now
-
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation https://www.fiercepharma.com/pharma/fda-advisory-committee-backs-lundbeck-and-otsukas-rexulti-use-alzheimers-disease-agitation-9
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind